Device / Technology News

RSS

Enrollment commences in Estech's HISTORIC-AF staged hybrid ablation study

Estech, a leader in minimally invasive cardiac surgery, announced today that the first three patients have been enrolled in the HISTORIC-AF European multi-center staged hybrid ablation clinical study.

5 Dec 2011

Herzig Eye Institute named TearScience's first Center of Excellence

TearScience, Inc., a privately-held medical device company, today announced Toronto-based Herzig Eye Institute, one of the leading authorities in laser vision correction and advanced cataract and refractive surgery, as its first Center of Excellence.

5 Dec 2011

MRG releases 2012 report on European markets for large-joint reconstructive implants

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the European market for large-joint reconstructive implants will grow moderately through 2016.

5 Dec 2011

Spacelabs Healthcare ranked top for Holter Monitoring solutions

According to MD Buyline's third quarter 2011 report, Spacelabs Healthcare is ranked #1 in overall customer satisfaction - having earned the industry's highest rating in all categories, including product performance, reliability, installation, implementation and applications training, as well as service response time and service repair quality - as related to Holter Monitoring solutions.

5 Dec 2011

New automated storage and pharmacy-grade refrigeration system from Talyst

Talyst, a leader in pharmacy automation, announced its new automated storage and pharmacy-grade refrigeration system, refrigerated AutoCarousel HD. The new technology ensures medications are kept at a safe temperature in the central pharmacy, while reducing energy costs and enhancing efficiency.

5 Dec 2011

gloStream to integrate DiagnosisOne's smartConsult CDS solution into CCHIT-certified EMR offering

DiagnosisOne, the clinical decision support and analytics company, today announced that gloStream has selected DiagnosisOne to provide clinical decision support (CDS) for its electronic medical record (EMR) solutions.

5 Dec 2011

Beyond Lucid Technologies launches MediView software platform

Beyond Lucid Technologies, Inc., a healthcare IT startup serving the emergency medical, disaster management, and First Response industries, today announced the launch of its MediView software platform at the mHealth Summit, and the publication of a first-of-its-kind white paper surveying technologies currently available to connect ambulances with hospitals via telemedicine.

5 Dec 2011

Toshiba adds two new enhancements to RADREX-i DR X-ray system

Improving patient care by enabling clinicians to better manage radiation dose for X-ray procedures, Toshiba America Medical Systems, Inc. has added two new enhancements to the RADREX-i digital radiographic (DR) X-ray system - DICOM Radiation Dose Structured Reporting and Reject Analysis software.

5 Dec 2011

Concord Medical hosts Twelfth Annual CCM Academic Conference in Beijing

Concord Medical Services Holdings Limited, operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it hosted the Twelfth Annual CCM Academic Conference in Beijing on December 3 and 4, 2011.

5 Dec 2011

Epilepsy patients can benefit from gamma knife radiosurgery

Neurosurgeons continue to explore minimally invasive surgery with gamma radiation (gamma knife surgery / GKS) in the treatment of brain lesions causing seizures and epilepsy. Studies of the procedure are showing it to be an effective alternative to invasive microsurgery for hypothalamic hamartomas and other lesions that lie deep within the brain.

5 Dec 2011

Study: 3D-TV may cause seizures in children and adolescents

Certain visual patterns and flashing images can provoke seizures in susceptible individuals, particularly among children and adolescents. Some media reports on the recent introduction of 3D-television sets suggest that this new technology may cause seizures in some viewers.

5 Dec 2011

Potential medical and social barriers to resective epilepsy surgery in patients after initial evaluation

Epilepsy surgery is safe, effective and often curative in selected candidates. Although candidates for epilepsy surgery in the United States are estimated between 100,000 and 200,000, fewer than 5,000 such surgeries are conducted each year. The cause of this disparity is multi-factorial, including an unexplained low level of referrals by physicians and choices made by patients themselves.

5 Dec 2011

Researchers uncover binding pocket of 'functional significance' in Ras oncoprotein

A drug discovery team at Genentech, Inc., has uncovered a chink in the molecular armor of Ras, the most commonly occurring oncogene, which is a gene that when mutated has the potential of causing cancer in humans.

5 Dec 2011

FDA guides novel diabetes device manufacturers towards easier approval

The U.S. Food and Drug Administration (FDA) has issued a rule book for scientists and device manufacturers who are working towards an artificial pancreas – a portable device to help people with type 1 diabetes control their blood sugar levels.

4 Dec 2011

La Jolla researchers create first cellular movies showing destruction underlying type 1 diabetes

A war is being waged in the pancreases of millions of people throughout the world. The siege leads to the development of type 1 diabetes and has been a battlefield largely hidden from view-- until now.

3 Dec 2011

New rapid blood test for early diagnosis of cryptococcosis

Research conducted at University of Nevada, Reno and licensed through the University's Technology Transfer Office is featured in the technology transfer publication "Better World Report" for a remarkable second year in a row.

3 Dec 2011

Four clinical centers to provide NovoTTF device treatment for recurrent GBM

Novocure, a commercial stage private oncology company, has announced that prominent neuro-oncologists at four clinical centers in the U.S. will be the first to provide access to its Tumor Treating Fields (TTFields) device, NovoTTF-100A System, for the treatment of recurrent glioblastoma multiforme. GBM is a deadly brain tumor affecting approximately 10,000 Americans each year.

3 Dec 2011